| James D Boblin, MD | |
|
3201 S 16th St, Ste 1005, Milwaukee, WI 53215-4537 | |
| (414) 384-4700 | |
| Not Available |
| Full Name | James D Boblin |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 3201 S 16th St, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538180997 | NPI | - | NPPES |
| 31383900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 26920 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James D Boblin, MD 2448 S 102nd St, Ste 125, West Allis, WI 53227-2466 Ph: (414) 328-3813 | James D Boblin, MD 3201 S 16th St, Ste 1005, Milwaukee, WI 53215-4537 Ph: (414) 384-4700 |
News Archive
According to a recently released report, during a 6-month period, doctors treated six cases of severe eye injuries in young children, caused by their squeezing capsules containing liquid washing detergent.
In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.
A group of Brazilian scientists have long conducted experiments with roundworms to investigate the role of schizophrenia-linked genes in patients' response to antipsychotic drugs. The results obtained thus far point to new ways of understanding resistance to certain classes of medication.
Stem Cell Therapy International, Inc. is proud to announce the execution of the Reorganization and Stock Purchase Agreement ("the Agreement") with Histostem Co., Ltd., a Korean company ("Histostem" and together with SCII, "the parties").
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
› Verified 6 days ago
Dr. Christopher E Wolfla, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Spine Care Clinic At Plank Road, Milwaukee, WI 53226 Phone: 414-805-9255 Fax: 414-955-0110 | |
Mr. Cully R White, DO Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2901 W Kinnickinnic River Parkway, Suite 201, Milwaukee, WI 53215 Phone: 414-649-3232 Fax: 414-385-1929 | |
Dr. Sean M Lew, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-266-6435 Fax: 414-955-0131 | |
Dr. Shekar N Kurpad, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1155 N Mayfair Rd, Spine Care Clinic At Plank Road, Milwaukee, WI 53226 Phone: 414-955-7188 Fax: 414-955-0110 | |
Huy Q Truong, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-5400 Fax: 414-955-0115 | |
Dr. Andrew V Beykovsky, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2301 N Lake Dr, Milwaukee, WI 53211 Phone: 142-987-1424 | |
Saman Shabani, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-8710 Fax: 414-805-1101 |